Insulin aspart, recombinant Subcutaneous and Rizatriptan Benzoate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Rizatriptan Benzoate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: rizatriptan
Brand name: Maxalt, Maxalt-MLT
Synonyms: Rizatriptan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Rizatriptan Orally Disintegrating Tablets
- Insulin aspart, recombinant Subcutaneous-Rizatriptan Tablets
- Insulin aspart, recombinant Subcutaneous-RMS
- Insulin aspart, recombinant Subcutaneous-Robafen AC
- Insulin aspart, recombinant Subcutaneous-Robafen Cough
- Insulin aspart, recombinant Subcutaneous-Robafen Cough Liquidgels
- Rizatriptan Benzoate-Insulin degludec
- Rizatriptan Benzoate-Insulin Degludec (U-100) Prefilled Pens
- Rizatriptan Benzoate-Insulin Degludec (U-100) Vials
- Rizatriptan Benzoate-Insulin Degludec (U-200) Prefilled Pens
- Rizatriptan Benzoate-Insulin degludec and liraglutide
- Rizatriptan Benzoate-Insulin degludec and liraglutide Subcutaneous